[1] Owan TE, Hodge DO, Herges RM, et al.  Trends in prevalence andoutcome of heart failure with preserved ejection fraction[J]. N Engl J Med, 2006, 355(3): 251-259.   doi: 10.1056/NEJMoa052256
[2] Matsuo S, Nakae I, Tsutamoto T, et al.  A novel clinical indicator using Tc-99m sestamibi for evaluating cardiac mitochondrial function in patients with cardiomyopathies[J]. J Nucl Cardiol, 2007, 14(2): 215-220.   doi: 10.1016/j.nuclcard.2006.10.022
[3] Matsuo S, Matsumoto T, Nakae I, et al.  Prognostic value of ECG-gated thallium-201 single-photon emission tomography in patients with coronary artery disease[J]. Ann Nucl Med, 2004, 18(7): 617-622.   doi: 10.1007/BF02984584
[4] Germano G, Kavanagh PB, Slomka PJ, et al.  Quantitation in gated perfusion SPECT imaging: the Cedars-Sinai approach[J]. J Nucl Cardiol, 2007, 14(4): 433-454.   doi: 10.1016/j.nuclcard.2007.06.008
[5] Matsuo S, Nakamura Y, Takahashi M, et al.  Effect of red wine and ethanol on production of nitric oxide in healthy subjects[J]. Am J Cardiol, 2001, 87(8): 1029-1031.   doi: 10.1016/S0002-9149(01)01446-1
[6] Matsuo S, Matsumoto T, Takashima H, et al.  The relationship between flow-mediated brachial artery vasodilation and coronary vasomotor responses to bradykinin: comparison with those to acetylcholine[J]. J Cardiovasc Pharmacol, 2004, 44(2): 164-170.   doi: 10.1097/00005344-200408000-00004
[7] Sciagrà R, Berti V, Genovese S, et al.  Reliability of myocardial perfusion gated SPECT for the reproducible evaluation of resting left ventricular functional parameters in long-term follow-up[J]. Eur J Nucl Med Mol Imaging, 2010, 37(9): 1722-1729.   doi: 10.1007/s00259-010-1444-y
[8] Matsuo S, Sato Y, Nakae I, et al.  Evaluation of cardiac resynchronization therapy in drugresistant dilated-phase hyper-trophic cardiomyopathy by means of Tc-99m sestamibi ECG-gated SPECT[J]. Ann Nucl Med, 2006, 20(9): 643-647.   doi: 10.1007/BF02984664
[9] Nakajima K, Matsuo S, Kawano M, et al.  The validity of multicenter common normal database for identifying myocardial ischemia: Japanese Society of Nuclear Medicine working group database[J]. Ann Nucl Med, 2010, 24(2): 99-105.   doi: 10.1007/s12149-009-0331-8
[10] Matsuo S, Nakajima K, Horie M, et al.  Prognostic value of normal stress myocardial perfusion imaging in Japanese population[J]. Circ J, 2008, 72(4): 611-617.
[11] Akhter N, Nakajima K, Okuda K, et al.  Regional wall thickening in gated myocardial perfusion SPECT in a Japanese population: effect of sex, radiotracer, rotation angles and frame rates[J]. Eur J Nucl Med Mol Imaging, 2008, 35(9): 1608-1615.   doi: 10.1007/s00259-008-0804-3
[12] NakajimaK, NishimuraT.  Inter-institution preference-based variability of ejection fraction and volumes using quantitative gated 99mTc-tetrofosmin: a multicentre study involving 106 hospitals[J]. Eur J Nucl Med Mol Imaging, 2006, 33(2): 127-133.   doi: 10.1007/s00259-005-1916-7
[13] Johnson LL, Verdesca SA, Aude WY, et al.  Postischemic stunning can affect left ventricular ejection fraction and regional wall motion on post-stress gated sestamibi tomograms[J]. J Am Coll Cardiol, 1997, 30(7): 1641-1648.   doi: 10.1016/S0735-1097(97)00388-4
[14] Nishimura T, Nakajima K, Kusuoka H, et al.  Prognostic study of risk stratification among Japanese patients with ischemic heart disease using gated myocardial perfusion SPECT: J-ACCESS study[J]. Eur J Nucl Med Mol Imaging, 2008, 35(2): 319-328.   doi: 10.1007/s00259-007-0608-x
[15] Matsuo S, Nakajima K, Yamasaki Y, et al.  Prognostic value of normal stress myocardial perfusion imaging and ventricular function in Japanese asymptomatic patients with type 2 diabetes—a study based on the J-ACCESS-2 database[J]. Circ J, 2010, 74(9): 1916-1921.   doi: 10.1253/circj.CJ-10-0098
[16] Shaw LJ, Hachamovitch R, Berman DS, et al.  The economic consequences of available diagnostic and prognostic strategies for the evaluation of stable angina patients: an observational assessment of the value of precatheterization ischemia. Economics of Noninvasive Diagnosis (END) Multicenter Study Group[J]. J Am Coll Cardiol, 1999, 33(3): 661-669.   doi: 10.1016/S0735-1097(98)00606-8
[17] Nakajima K, Yamasaki Y, Kusuoka H, et al.  Cardiovascular events in Japanese asymptomatic patients with type 2 diabetes: a 1-year interim report of a J-ACCESS 2 investigation using myocardial perfusion imaging[J]. Eur J Nucl Med Mol Imaging, 2009, 36(12): 2049-2057.   doi: 10.1007/s00259-009-1207-9
[18] Hachamovitch R, Berman DS, Shaw LJ, et al.  Incremental prognostic value of myocardial perfusion single photon emission computed tomography for the prediction of cardiac death: differential stratification for risk of cardiac death and myocardial infarction[J]. Circulation, 1998, 97(6): 535-543.   doi: 10.1161/01.CIR.97.6.535
[19] Piccini JP, Horton JR, Shaw LK, et al.  Single-photon emission computed tomography myocardial perfusion defects are associated with an increased risk of all-ause death, cardiovascular death, and sudden cardiac death[J]. Circ Cardiovasc Imaging, 2008, 1(3): 180-188.   doi: 10.1161/CIRCIMAGING.108.776484
[20] Iskandrian AS, Hakki AH, Kane SA, et al.  Rest and redistribution thallium-201 myocardial scintigraphy to predict improvement in left ventricular function after coronary arterial bypass grafting[J]. Am Jcardiol, 1983, 51(8): 1312-1316.   doi: 10.1016/0002-9149(83)90304-1
[21] Haque T, Furukawa T, Yoshida S, et al.  Echocardiography and fatty acid single photon emission tomography in predicting reversibility of regional left ventricular dysfunction after coronary angioplasty[J]. Eur Heart J, 1998, 19(2): 332-341.   doi: 10.1053/euhj.1997.0734
[22] Pavlovic SV, Sobic-Saranovic DP, Beleslin BD, et al.  One-year follow-up of myocardial perfusion and function evaluated by gated SPECT MIBI in patients with earlier myocardial infarction and chronic total occlusion[J]. Nucl Med Commun, 2009, 30(1): 68-75.   doi: 10.1097/MNM.0b013e32831a40dd
[23] Allman KC, Shaw LJ, Hachamovitch R, et al.  Myocardial viability testing and impact of revascularization on prognosis in patients with coronary artery disease and left ventricular dysfunction: a metaanalysis[J]. J Am Coll Cardiol, 2002, 39(7): 1151-1158.   doi: 10.1016/S0735-1097(02)01726-6
[24] Korosoglou G, Lehrke S, Wochele A, et al.  Strain-encoded CMR for the detection of inducible ischemia during intermediate stress[J]. JACC Cardiovasc Imaging, 2010, 3(4): 361-371.   doi: 10.1016/j.jcmg.2009.11.015
[25] Nagamachi S, Wakamatsu H, Fujita S, et al.  Assessment of diastolic function using 16-frame 201Tl gated myocardial perfusion SPECT: a comparative study of QGS2 and pFAST2[J]. Ann Nucl Med, 2008, 22(2): 115-122.   doi: 10.1007/s12149-007-0091-2
[26] Nakae I, Matsuo S, Tsutamoto T, et al.  Assessment of cardiacfunction in patients with heart disease by quantitative gated myocardialperfusionSPECT[J]. AnnNuclMed, 2007, 21(6): 315-323.
[27] Akincioglu C, Berman DS, Nishina H, et al.  Assessment of diastolic function using 16-frame 99mTc-sestamibi gated myocardial perfusion SPECT: normal values[J]. J Nucl Med, 2005, 46(7): 1102-1108.
[28] Matsuo S, Nakamura Y, Tsutamoto T, et al.  Impairments of myocardial sympathetic activity may reflect the progression of myocardial damage or dysfunction in hypertrophic cardiomyopathy[J]. J Nucl Cardiol, 2002, 9(4): 407-412.   doi: 10.1067/mnc.2002.122765
[29] Matsuo S, Takahashi M, Nakamura Y, et al.  Evaluation of cardiac sympathetic innervation with iodine-123-metaiodobenzyl-guanidine imaging in silent myocardial ischemia[J]. J Nucl Med, 1996, 37(5): 712-717.
[30] Matsuo S, Nakajima K, Okuda K, et al.  Standardization of the heart-to-mediastinum ratio of 123I-labelled-metaiodobenzylguanidine uptake using the dual energy window method: feasibility of correction with different camera-collimator combinations[J]. Eur J Nucl Med Mol Imaging, 2009, 36(4): 560-566.   doi: 10.1007/s00259-008-0971-2
[31] Matsuo S, Nakae I, Masuda D, et al.  Dilated cardiomyopathy relieved as a result of beta-blocker therapy: a case report—key points in assessment of prognosis based on MIBG myocardial scintigraphyandBNPlevels[J]. AnnNuclMed, 2005, 19(3): 243-246.
[32] Yamazaki J, Muto H, Kabano T, et al.  Evaluation of beta-blocker therapy in patients with dilated cardiomyopathy—Clinical meaning of iodine 123-metaiodo-benzylguanidine myocardial single-photon emission computed tomography[J]. AmHeartJ, 2001, 141(4): 645-652.
[33] Nishioka SA, Martinelli Filho M, Brändao SC, et al.  Cardiac sympathetic activity pre and post resynchronization therapy evaluated by 123I-MIBG myocardial scintigraphy[J]. J Nucl Cardiol, 2007, 14(6): 852-859.   doi: 10.1016/j.nuclcard.2007.08.004
[34] Matsuo S, Matsumoto T, Nakae I, et al.  Evaluation of cardiac resynchronization therapy in drug-resistant idiopathic dilated cardiomyopathy by means of technetium-99m tetrofosmin electrocar-diography-gated single-photon emission computed tomography[J]. Exp Clin Cardiol, 2004, 9(4): 248-250.
[35] Matsuo S, Nakamura Y, Matsumoto T, et al.  Prognostic value of iodine-123 metaiodobenzylguanidine imaging in patients with heart failure[J]. Exp Clin Cardiol, 2003, 8(2): 95-98.
[36] Nakata T, Wakabayashi T, Kyuma M, et al.  Cardiac metaiodobenzylguanidine activity can predict the long-term efficacy of aiotensin-converting enzyme inhibitors and/or beta-adreno-ceptor blockers in patients with heart failure[J]. Eur J Nucl Med Mol Imaging, 2005, 32(2): 186-194.   doi: 10.1007/s00259-004-1624-8
[37] Jacobson AF, Senior R, Cerqueira MD, et al.  Myocardial iodine-123 meta-iodobenzylguanidine imaging and cardiac events in heart failure[J]. Results of the prospective ADMIRE-HF(AdreView Myocardial Imaging for Risk Evaluation in Heart Failure)study. J Am Coll Cardiol, 2010, 55(20): 2212-2221.
[38] Kawamoto M, Tamaki N, Yonekura Y, et al.  Combined study with I-123 fatty acid and thallium-201 to assess ischemic myocardium: comparison with thallium redistribution and glucose metabolism[J]. Ann Nucl Med, 1994, 8(1): 47-54.   doi: 10.1007/BF03164986
[39] Matsuo S, Nakamura Y, Takahashi M, et al.  Myocardial metabolic abnormalities in hypertrophic cardiomyopathy assessed by iodine-123-labeled beta-methyl-branched fatty acid myocardial scintigraphy and its relation to exercise-induced ischemia[J]. Jpn Circ J, 1998, 62(3): 167-172.   doi: 10.1253/jcj.62.167
[40] Ishida Y, Yasumura Y, Nagaya N, et al.  Myocardial imaging with 1 2 3 I-BMIPP in patients with congestive heart failure[J]. Int J Card Imaging, 1999, 15(1): 71-77.   doi: 10.1023/A:1006152804670
[41] Yazaki Y, Isobe M, Takahashi W, et al.  Assessment of myocardial fatty acid metabolic abnormalities in patients with idiopathic dilated cardiomyopathy using 123I BMIPP SPECT: correlation with clinicopathological findings and clinical course[J]. Heart, 1999, 81(2): 153-159.   doi: 10.1136/hrt.81.2.153
[42] Bruder O, Wagner A, Jensen CJ, et al.  Myocardial scar visualized by cardiovascular magnetic resonance imaging predicts major adverse events in patients with hypertrophic cardiomyopathy[J]. J Am Coll Cardiol, 2010, 56(11): 875-887.   doi: 10.1016/j.jacc.2010.05.007
[43] Chang GY, Xie X, Wu JC.  Overview of stem cells and imaging modalities for cardiovascular diseases[J]. J Nucl Cardiol, 2006, 13(4): 554-569.   doi: 10.1016/j.nuclcard.2006.05.012
[44] Matsuo S, Nakae I, Masuda D, et al.  Scintigraphic evaluation of cardiac metabolism and sympathetic nerve function in alcoholic cardiomyopathy[J]. Intern Med, 2006, 45(7): 465-467.   doi: 10.2169/internalmedicine.45.1696
[45] Matsuo S, Nakae I, Takada M, et al.  Noninvasive identification of myocardial sympathetic and metabolic abnormalities in a patient with restrictive cardiomyopathy—in comparison with perfusion imaging[J]. Ann Nucl Med, 2002, 16(8): 569-572.   doi: 10.1007/BF02988635
[46] Wichter T, Hindricks G, Lerch H, et al.  Regional myocardial sympathetic dysinnervation in arrhythmogenic right ventricular cardiomyopathy[J]. An analysis using 123I-meta-iodobenzylguanidine scintigraphy. Circulation, 1994, 89(2): 667-683.
[47] Akashi YJ, Nakazawa K, Sakakibara M, et al.  123I-MIBG myocardial scintigraphy in patients with"takotsubo"cardiomyopathy[J]. J Nucl Med, 2004, 45(7): 1121-1127.
[48] Matsuo S, Nakamura Y, Takahashi M, et al.  Cardiac sympathetic dysfunction in an athlete's heart detected by 123I-metaiodobenzylguanidine scintigraphy[J]. Jpn Circ J, 2001, 65(5): 371-374.   doi: 10.1253/jcj.65.371